• Online Features  This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

CAPT MARK W. WOLFE, MC, USAF; CAPT ROBERT M. SAAD, MC, USAF
Biloxi, Miss

Arch Intern Med. 1989;149(6):1462-1463.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—On the surface, the recent article by Abraham and colleagues¹ would seem to address a provocative question: whether or not the progression of nondiabetic chronic renal disease can be affected by the administration of the angiotensin-converting enzyme inhibitor (ACEI) enalapril. Closer inspection reveals little data concerning this patient group. Of the 10 patients able to complete short-term therapy, 4 actually had diabetic nephropathy and only 2 of the 6 patients with nondiabetic renal disease had significant proteinuria (Nos. 4 and 10). Only 1 of these 2 patients (No. 4) seemed to have a significant reduction in proteinuria, but he was withdrawn from the study before the long-term phase of the study could be completed. The authors state that "the rate of progression of renal insufficiency seemed to slacken in 3 of 4 patients with diabetic nephropathy," based on changes in slopes of serum creatinine curves (the . . . [Full Text PDF of this Article]

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?